News

Subcommittee discusses Concealed Carry Study This week, the Arkansas Legislative Council Game and Fish/State Police Subcommittee held a meeting to discuss concealed carry laws in Arkansas. This meeting was part of a series of meetings held as part of the Arkansas Firearms and Concealed Carry Laws Study.

LITTLE ROCK - Logan Perry of Flippin, has been named to the Dean’s List for the Fall 2023 semester at the University of Arkansas at Little Rock. The Dean’s List recognized more than 1,175 students with superior academic performances at the end of the semester.

The Senate Education Committee has begun its review of the adequacy and equity of Arkansas public school funding. Lawmakers conduct a thorough review every two years, with the help of legislative staff.

Kimberly Jones, ED MOUNTAIN HOME – Nonprofits in Marion, Baxter, Fulton and Izard counties can go to arcf.org/givingtree to apply online for Giving Tree Grants through Twin Lakes Community Foundation, an affiliate of Arkansas Community Foundation. Applications must be submitted online by February 15.

LITTLE ROCK (AP) — Former Arkansas Gov. Asa Hutchinson dropped his long-shot bid for the Republican presidential nomination on Tuesday, ending a candidacy that was a throwback to an earlier era of the GOP but ultimately failed to resonate in a party now dominated by Donald Trump.

**Menu subject to change, Suggested Donation of $4.00. If you would like to substitute a salad, please call 870-453-8488 No later than 11 a.m. Under 60 and carry out $7.00 Lunch served Mon-Fri 11:30 a.m. to 12:15 p.m.** Monday: Hamburger on Bun, Creamy Coleslaw, Mustard Potato Salad, Pineapple Fluff Tuesday: Chicken Tenders, Macaroni & Cheese, Baby Lima Beans, Wheat Bread, Chilled Peaches Wednesday: Goulash, Tossed Salad, Wheat Roll, Pound Cake w/ Strawberries.

The first bottle of a reagent that can be used in life-saving cancer therapy developed by Our Blood Institute has been distributed by OBI LittleRock ─ Our Blood Institute is excited to announce a groundbreaking milestone. For the past two years OBI has been developing a method that would allow blood donated by our dedicated donors to make reagents used for life-saving cancer therapies.